Intrauterine programming of disorders of brain function in later life;Intrauterine programmierung von störungen der hirnfunktion im späteren leben

Gynakologisch-geburtshilfliche Rundschau

Volumn 49, Issue 1, 2009, Pages 13-28

  Schwab, Matthias ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Brain function; Depression; Fetal programming; Glucocorticoids; Malnutrition; Prenatal stress

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; 4 AMINOBUTYRIC ACID; ACETYLCHOLINE; BETAMETHASONE; DEXAMETHASONE; DOPAMINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; NORADRENALIN; SEROTONIN; SOMATOMEDIN; STRESS HORMONE;

ARTERIOSCLEROSIS; ATTENTION DEFICIT DISORDER; BRAIN DEVELOPMENT; BRAIN FUNCTION; COGNITIVE DEFECT; CORTICOSTEROID THERAPY; DEPRESSION; DOPAMINERGIC SYSTEM; EPIGENETICS; FETAL MALNUTRITION; GABAERGIC SYSTEM; GENOME IMPRINTING; HEART FAILURE; HUMAN; HYPERCORTISOLISM; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; NONHUMAN; NONREM SLEEP; OBESITY; PLACENTA INSUFFICIENCY; POSTNATAL GROWTH; PRENATAL STRESS; RECEPTOR DOWN REGULATION; REM SLEEP; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; VERY LOW BIRTH WEIGHT; ARTICLE; BRAIN; BRAIN DISEASE; INTRAUTERINE GROWTH RETARDATION; PATHOPHYSIOLOGY; PRENATAL DEVELOPMENT;

BRAIN; BRAIN DISEASES; FETAL GROWTH RETARDATION; HUMANS;

EID: 60249100732     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000184442     Document Type: Review

References (270)

1. Meaney MJ, Szyf M: Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin Neurosci 2005;7:103-123.
2. Sloboda DM, Moss TJ, Li S, Matthews SG, Challis JR, Newnham JP: Expression of glucocorticoid receptor, mineralocorticoid receptor, and 11beta-hydroxysteroid dehydrogenase 1 and 2 in the fetal and postnatal ovine hippocampus: ontogeny and effects of prenatal glucocorticoid exposure. J Endocrinol 2008;197:213-220.
3. Wilkinson LS, Davies W, Isles AR: Genomic imprinting effects on brain development and function. Nat Rev Neurosci 2007;8:832-843.
4. Gicquel C, El-Osta A, Le Bouc Y: Epigenetic regulation and fetal programming. Best Pract Res Clin Endocrinol Metab 2008;22:1-16.
5. Barker DJP: Mothers, Babies and Health in Later Life. Edinburgh, Churchill Livingstone, 1998.
6. Martyn CN, Greenwald SE: A hypothesis about a mechanism for the programming of blood pressure and vascular disease in early life. Clin Exp Pharmacol Physiol 2001;28:948-951.
7. Kunes J, Zicha J: Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view. Clin Sci (Lond) 2006;111:295-305.
8. Zicha J, Kunes J: Ontogenetic aspects of hypertension development: analysis in the rat. Physiol Rev 1999;79:1227-1282.
9. Szitányi P, Janda J, Poledne R: Intrauterine undernutrition and programming as a new risk of cardiovascular disease in later life. Physiol Res 2003;52:389-395.
10. Elgen I, Sommerfelt K, Ellertsen B: Cognitive performance in a low birth weight cohort at 5 and 11 years of age. Pediatr Neurol 2003;29:111-116.
11. Matte TD, Bresnahan M, Begg MD, Susser E: Influence of variation in birth weight within normal range and within sibships on IQ at age 7 years: cohort study. Br Med J 2001;323:310-314.
12. Morley R, Lucas A: Nutrition and cognitive development. Br Med Bull 1997;53:123-134.
13. Olness K: Effects on brain development leading to cognitive impairment: a worldwide epidemic. J Dev Behav Pediatr 2003;24:120-130.
14. Ortiz-Mantilla S, Choudhury N, Leevers H, Benasich AA: Understanding language and cognitive deficits in very low birth weight children. Dev Psychobiol 2008;50:107-126.
15. Reichman NE: Low birth weight and school readiness. Future Child 2005;15:91-116.
16. Richards M, Hardy R, Kuh D, Wadsworth ME: Birthweight, postnatal growth and cognitive function in a national UK birth cohort. Int J Epidemiol 2002;31:342-348.
17. Santos DN, Assis AM, Bastos AC, Santos LM, Santos CA, Strina A, Prado MS, Almeida-Filho NM, Rodrigues LC, Barreto ML: Determinants of cognitive function in childhood: a cohort study in a middle income context. BMC Public Health 2008;8:202.
18. Shenkin SD, Starr JM, Deary IJ: Birth weight and cognitive ability in childhood: a systematic review. Psychol Bull 2004;130:989-1013.
19. Tong S, Baghurst P, McMichael A: Birth-weight and cognitive development during childhood. J Paediatr Child Health 2006;42:98-103.
20. Walker SP, Thame MM, Chang SM, Bennett F, Forrester TE: Association of growth in utero with cognitive function at age 6-8 years. Early Hum Dev 2007;83:355-360.
21. Erhard HW, Boissy A, Rae MT, Rhind SM: Effects of prenatal undernutrition on emotional reactivity and cognitive flexibility in adult sheep. Behav Brain Res 2004;151:25-35.
22. Corbett SS, Drewett RF, Durham M, Tymms P, Wright CM: The relationship between birthweight, weight gain in infancy, and educational attainment in childhood. Paediatr Perinat Epidemiol 2007;21:57-64.
23. Gale CR, O'Callaghan FJ, Godfrey KM, Law CM, Martyn CN: Critical periods of brain growth and cognitive function in children. Brain 2004;127:321-329.
24. Heinonen K, Räikkönen K, Pesonen AK, Kajantie E, Andersson S, Eriksson JG, Niemelä A, Vartia T, Peltola J, Lano A: Prenatal and postnatal growth and cognitive abilities at 56 months of age: a longitudinal study of infants born at term. Pediatrics 2008;121:e1325-e1333.
25. Silva A, Metha Z, O'Callaghan FJ: The relative effect of size at birth, postnatal growth and social factors on cognitive function in late childhood. Ann Epidemiol 2006;16:469-476.
26. Banerjee TD, Middleton F, Faraone SV: Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr 2007;96:1269-1274.
27. Alati R, Lawlor DA, Mamun AA, Williams GM, Najman JM, O'Callaghan M, Bor W: Is there a fetal origin of depression? Evidence from the Mater University Study of Pregnancy and its outcomes. Am J Epidemiol 2007;165:575-582.
28. Bellingham-Young DA, Adamson-Macedo EN: Foetal origins theory: links with adult depression and general self-efficacy. Neuroendocrinol Lett 2003;24:412-416.
29. Brown AS, van Os J, Driessens C, Hoek HW, Susser ES: Further evidence of relation between prenatal famine and major affective disorder. Am J Psychiatry 2000;157:190-195.
30. Casper RC: Nutrients, neurodevelopment, and mood. Curr Psychiatry Rep 2004;6:425-429.
31. Inskip HM, Dunn N, Godfrey KM, Cooper C, Kendrick T;Southampton Women's Survey Study Group: Is birth weight associated with risk of depressive symptoms in young women? Evidence from the Southampton Women's Survey. Am J Epidemiol 2008;167:164-168.
32. Kajantie E: Fetal origins of stress-related adult disease. Ann NY Acad Sci 2006;1083:11-27.
33. Kyle UG, Pichard C: The Dutch Famine of 1944-1945: a pathophysiological model of long-term consequences of wasting disease. Curr Opin Clin Nutr Metab Care 2006;9:388-394.
34. Nomura Y, Wickramaratne PJ, Pilowsky DJ, Newcorn JH, Bruder-Costello B, Davey C, Fifer WP, Brooks-Gunn J, Weissman MM: Low birth weight and risk of affective disorders and selected medical illness in offspring at high and low risk for depression. Compr Psychiatry 2007;48:470-478.
35. Rice F, Harold GT, Thapar A: The effect of birth-weight with genetic susceptibility on depressive symptoms in childhood and adolescence. Eur Child Adolesc Psychiatry 2006;15:383-391.
36. Paile-Hyvärinen M, Räikkönen K, Forsén T, Kajantie E, YlihärsiläH, Salonen MK, Osmond C, Eriksson JG: Depression and its association with diabetes, cardiovascular disease, and birth weight. Ann Med 2007;39:634-640.
37. Thompson C, Syddall H, Rodin I, Osmond C, Barker DJ: Birth weight and the risk of depressive disorder in late life. Br J Psychiatry 2001;179:450-455.
38. Vasiliadis HM, Gilman SE, Buka SL: Fetal growth restriction and the development of major depression. Acta Psychiatr Scand 2008;117:306-312.
39. Kelly J, Murray RM: What risk factors tell us about the causes of schizophrenia and related psychoses. Curr Psychiatry Rep 2000;2:378-385.
40. Perrin MA, Chen H, Sandberg DE, Malaspina D, Brown AS: Growth trajectory during early life and risk of adult schizophrenia. Br J Psychiatry 2007;191:512-520.
41. Reser JE: Schizophrenia and phenotypic plasticity: schizophrenia may represent a predictive, adaptive response to severe environmental adversity that allows both bioenergetic thrift and a defensive behavioral strategy. Med Hypotheses 2007;69:383-394.
42. St Clair D, Xu M, Wang P, Yu Y, Fang Y, Zhang F, Zheng X, Gu N, Feng G, Sham P, He L: Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. JAMA 2005;294:557-562.
43. Jaiswal AK, Upadhyay SN, Satyan KS, Bhattacharya SK: Behavioural effects of prenatal and postnatal undernutrition in rats. Indian J Exp Biol 1996;34:1216-1219.
44. Rodricks CL, Rose IA, Camm EJ, Jenkin G, Miller SL, Gibbs ME: The effect of prenatal hypoxia and malnutrition on memory consolidation in the chick. Brain Res Dev Brain Res 2004;148:113-119.
45. Vieau D, Sebaai N, Léonhardt M, Dutriez-Casteloot I, Molendi-Coste O, Laborie C, Breton C, Deloof S, Lesage J: HPA axis programming by maternal undernutrition in the male rat offspring. Psychoneuroendocrinology 2007;32(suppl 1):S16-S20.
46. Chowen JA, Goya L, Ramos S, Busiguina S, Garcia-Segura LM, Argente J, Pascual-Leone AM: Effects of early undernutrition on the brain insulin-like growth factor-I system. J Neuroendocrinol 2002;14:163-169.
47. Fowden AL: The insulin-like growth factors and feto-placental growth. Placenta 2003;24:803-812.
48. Gluckman PD, Harding JE: Fetal growth retardation: underlying endocrine mechanisms and postnatal consequences. Acta Paediatr Suppl 1997;422:69-72.
49. Thissen JP, Ketelslegers JM, Underwood LE: Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994;15:80-101.
50. Seckl JR: Glucocorticoids, developmental 'programming' and the risk of affective dysfunction. Prog Brain Res 2008;167:17-34.
51. Welberg LA, Seckl JR: Prenatal stress, glucocorticoids and the programming of the brain. J Neuroendocrinol 2001;13:113-128.
52. Mastorakos G, Ilias I: Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann NY Acad Sci 2003;997:136-149.
53. Nicholson RC, King BR, Smith R: Complex regulatory interactions control CRH gene expression. Front Biosci 2004;9:32-39.
54. Weinstock M: The potential influence of maternal stress hormones on development and mental health of the offspring. Brain Behav Immun 2005;19:296-308.
55. Bzoskie L, Blount L, Kashiwai K, Tseng YT, Hay WW Jr, Padbury JF: Placental norepinephrine clearance: in vivo measurement and physiological role. Am J Physiol 1995;269:E145-E149.
56. Stevens AD, Lumbers ER: Effects of intravenous infusions of noradrenaline into the pregnant ewe on uterine blood flow, fetal renal function, and lung liquid flow. Can J Physiol Pharmacol 1995;73:202-208.
57. Benyshek DC: The developmental origins of obesity and related health disorders - prenatal and perinatal factors. Coll Antropol 2007;31:11-17.
58. Bouret SG, Simerly RB: Developmental programming of hypothalamic feeding circuits. Clin Genet 2006;70:295-301.
59. Bréant B, Gesina E, Blondeau B: Nutrition, glucocorticoids and pancreas development. Horm Res 2006;65(suppl 3):98-104.
60. James WP: The epidemiology of obesity: the size of the problem. J Intern Med 2008;263:336-352.
61. Knip M, Akerblom HK: Early nutrition and later diabetes risk. Adv Exp Med Biol 2005;569:142-150.
62. McMillen IC, Robinson JS: Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005;85:571-633.
63. Phillips DI, Jones A, Goulden PA: Birth weight, stress, and the metabolic syndrome in adult life. Ann NY Acad Sci 2006;1083:28-36.
64. Plagemann A: Perinatal programming and functional teratogenesis: impact on body weight regulation and obesity. Physiol Behav 2005;86:661-668.
65. Simmons R: Developmental origins of adult metabolic disease. Endocrinol Metab Clin North Am 2006;35:193-204.
66. Taylor PD, Poston L: Developmental programming of obesity in mammals. Exp Physiol 2007;92:287-298.
67. Thureen PJ: The neonatologist's dilemma: catch-up growth or beneficial undernutrition in very low birth weight infants - what are optimal growth rates? J Pediatr Gastroenterol Nutr 2007;45(suppl 3):S152-S154.
68. Wells JC, Chomtho S, Fewtrell MS: Programming of body composition by early growth and nutrition. Proc Nutr Soc 2007;66:423-434.
69. Bagby SP: Maternal nutrition, low nephron number, and hypertension in later life: pathways of nutritional programming. J Nutr 2007;137:1066-1072.
70. Barker DJ, Bagby SP, Hanson MA: Mechanisms of disease: in utero programming in the pathogenesis of hypertension. Nat Clin Pract Nephrol 2006;2:700-707.
71. Gardner DS, Bell RC, Symonds ME: Fetal mechanisms that lead to later hypertension. Curr Drug Targets 2007;8:894-905.
72. Hershkovitz D, Burbea Z, Skorecki K, Brenner BM: Fetal programming of adult kidney disease: cellular and molecular mechanisms. Clin J Am Soc Nephrol 2007;2:334-342.
73. Ingelfinger JR: Disparities in renal endowment: causes and consequences. Adv Chronic Kidney Dis 2008;15:107-114.
74. Langley-Evans SC: Developmental programming of health and disease. Proc Nutr Soc 2006;65:97-105.
75. López-Bermejo A, Sitjar C, Cabacas A, Vázquez-Ruíz M, García-González MM, Mora C, Soriano P, Calvo M, Ibáñez L: Prenatal programming of renal function: the estimated glomerular filtration rate is influenced by size at birth in apparently healthy children. Pediatr Res 2008;64:97-99.
76. Ojeda NB, Grigore D, Alexander BT: Intrauterine growth restriction: fetal programming of hypertension and kidney disease. Adv Chronic Kidney Dis 2008;15:101-106.
77. Schreuder MF, Nauta J: Prenatal programming of nephron number and blood pressure. Kidney Int 2007;72:265-268.
78. Vuguin PM: Animal models for small for gestational age and fetal programming of adult disease. Horm Res 2007;68:113-123.
79. Woods LL: Maternal nutrition and predisposition to later kidney disease. Curr Drug Targets 2007;8:906-913.
80. Zandi-Nejad K, Luyckx VA, Brenner BM: Adult hypertension and kidney disease: the role of fetal programming. Hypertension 2006;47:502-508.
81. Dagan A, Kwon HM, Dwarakanath V, Baum M: Effect of renal denervation on prenatal programming of hypertension and renal tubular transporter abundance. Am J Physiol Renal Physiol 2008;295:F29-F34.
82. Wyrwoll CS, Mark PJ, Waddell BJ: Developmental programming of renal glucocorticoid sensitivity and the renin-angiotensin system. Hypertension 2007;50:579-584.
83. Gardner DS, Van Bon BW, Dandrea J, Goddard PJ, May SF, Wilson V, Stephenson T, Symonds ME: Effect of periconceptional undernutrition and gender on hypothalamic-pituitary-adrenal axis function in young adult sheep. J Endocrinol 2006;190:203-212.
84. O'Regan D, Kenyon CJ, Seckl JR, Holmes MC: Prenatal dexamethasone 'programmes' hypotension, but stress-induced hypertension in adult offspring. J Endocrinol 2008;196:343-352.
85. +-ATPase activity present in first generation offspring of lard-fed rats does not persist to the second generation. Exp Physiol 2007;92:583-589.
86. Khorram O, Momeni M, Ferrini M, Desai M, Ross MG: In utero undernutrition in rats induces increased vascular smooth muscle content in the offspring. Am J Obstet Gynecol 2007;196:486.e1-8.
87. Lamireau D, Nuyt AM, Hou X, Bernier S, Beauchamp M, Gobeil F Jr, Lahaie I, Varma DR, Chemtob S: Altered vascular function in fetal programming of hypertension. Stroke 2002;33:2992-2998.
88. Torrens C, Brawley L, Barker AC, Itoh S, Poston L, Hanson MA: Maternal protein restriction in the rat impairs resistance artery but not conduit artery function in pregnant offspring. J Physiol 2003;547:77-84.
89. Tauzin L, Risso F, Buffat C, Serra G, Simeoni U: Vascular mechanisms in the developmental programming of cardio-vascular disease. Pediatr Med Chir 2005;27:18-23.
90. Gibbons A: Solving the brain's energy crisis. Science 1998;280:1345-1347.
91. Sontag LW: The significance of environmental differences. Am J Obstet Gynecol 1941;42:996-1003.
92. Beversdorf DQ, Manning SE, Hillier A, Anderson SL, Nordgren RE, Walters SE, Nagaraja HN, Cooley WC, Gaelic SE, Bauman ML: Timing of prenatal stressors and autism. J Autism Dev Disord 2005;35:471-478.
93. Drake AJ, Tang JI, Nyirenda MJ: Mechanisms underlying the role of glucocorticoids in the early life programming of adult disease. Clin Sci (Lond) 2007;113:219-232.
94. Fumagalli F, Molteni R, Racagni G, Riva MA: Stress during development: impact on neuroplasticity and relevance to psychopathology. Prog Neurobiol 2007;81:197-217.
95. Huizink AC, Mulder EJ, Buitelaar JK: Prenatal stress and risk for psychopathology: specific effects or induction of general susceptibility? Psychol Bull 2004;130:115-142.
96. Huttunen MO, Machon RA, Mednick SA: Prenatal factors in the pathogenesis of schizophrenia. Br J Psychiatry Suppl 1994;15-19.
97. Khashan AS, Abel KM, McNamee R, Pedersen MG, Webb RT, Baker PN, Kenny LC, Mortensen PB: Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events. Arch Gen Psychiatry 2008;65:146-152.
98. Kinney DK, Munir KM, Crowley DJ, Miller AM: Prenatal stress and risk for autism. Neurosci Biobehav Rev 2008;32:1519-1532.
99. Koenig JI, Kirkpatrick B, Lee P: Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology 2002;27:309-318.
100. Meijer A: Child psychiatric sequelae of maternal war stress. Acta Psychiatr Scand 1985;72:505-511.
101. Sloboda DM, Challis JR, Moss TJ, Newnham JP: Synthetic glucocorticoids: antenatal administration and long-term implications. Curr Pharm Des 2005;11:1459-1472.
102. Talge NM, Neal C, Glover V: Early Stress, Translational Research and Prevention Science Network: fetal and neonatal experience on child and adolescent mental health. Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? J Child Psychol Psychiatry 2007;48:245-261.
103. Van den Bergh BR, Mulder EJ, Mennes M, Glover V: Antenatal maternal anxiety and stress and the neurobehavioural development of the fetus and child: links and possible mechanisms. A review. Neurosci Biobehav Rev 2005;29:237-258.
104. Weinstock M: The long-term behavioural consequences of prenatal stress. Neurosci Biobehav Rev 2008;32:1073-1086.
105. Brand SR, Engel SM, Canfield RL, Yehuda R: The effect of maternal PTSD following in utero trauma exposure on behavior and temperament in the 9-month-old infant. Ann NY Acad Sci 2006;1071:454-458.
106. Smits L, Krabbendam L, de Bie R, Essed G, van Os J: Lower birth weight of Dutch neonates who were in utero at the time of the 9/11 attacks. J Psychosom Res 2006;61:715-717.
107. van Os J, Selten JP: Prenatal exposure to maternal stress and subsequent schizophrenia: the May 1940 invasion of the Netherlands. Br J Psychiatry 1998;172:324-332.
108. Watson JB, Mednick SA, Huttunen M, Wang X: Prenatal teratogens and the development of adult mental illness. Dev Psychopathol 1999;11:457-466.
109. Yehuda R, Engel SM, Brand SR, Seckl J, Marcus SM, Berkowitz GS: Transgenerational effects of posttraumatic stress disorder in babies of mothers exposed to the World Trade Center attacks during pregnancy. J Clin Endocrinol Metab 2005;90:4115-4118.
110. Claes SJ: CRH, stress, and major depression: a psychobiological interplay. Vitam Horm 2004;69:117-150.
111. Deuschle M, Schweiger U, Weber B, Gotthardt U, Korner A, Schmider J, Standhardt H, Lammers CH, Heuser I: Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab 1997;82:234-238.
112. NIH: Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA 1995;273:413-418.
113. Diederich S, Scholz T, Eigendorff E, Bumke-Vogt Ch, Quinkler M, Exner P, Pfeiffer AF, Oelkers W, Bähr V: Pharmacodynamics and pharmacokinetics of synthetic mineralocorticoids and glucocorticoids: receptor transactivation and prereceptor metabolism by 11beta-hydroxysteroid-dehydrogenases. Horm Metab Res 2004;36:423-429.
114. Siebe H, Baude G, Lichtenstein I, Wang D, Bühler H, Hoyer GA, Hierholzer K: Metabolism of dexamethasone: sites and activity in mammalian tissues. Ren Physiol Biochem 1993;16:79-88.
115. Murphy VE, Fittock RJ, Zarzycki PK, Delahunty MM, Smith R, Clifton VL: Metabolism of synthetic steroids by the human placenta. Placenta 2007;28:39-46.
116. Schleussner E, Arnscheidt C, Müller T, Schneider U, Haueisen J, Schwab K, Schwab M: Effects of antenatal glucocorticoids on human fetal cortical function detected by fetal magnetencephalography. J Soc Gynecol Invest 2004;11(suppl):69.
117. Schwab M, Rödel M, Schmidt K, Müller T, Schubert H, Anwar MA, Nathanielsz PW: Nonlinear changes of electrocortical activity after antenatal betamethasone treatment in fetal sheep. J Physiol (Lond) 2001;531:535-543.
118. Derks JB, Mulder EJ, Visser GH: The effects of maternal betamethasone administration on the fetus. Br J Obstet Gynaecol 1995;102:40-46.
119. Frusca T, Soregaroli M, Valcamonico A, Scalvi L, Bonera R, Bianchi U: Effect of betamethasone on computerized cardiotocographic parameters in preterm growth-restricted fetuses with and without cerebral vasodilation. Gynecol Obstet Invest 2001;52:194-197.
120. Magee LA, Dawes GS, Moulden M, Redman CW: A randomised controlled comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. Br J Obstet Gynaecol 1997;104:1233-1238.
121. Mulder EJ, Derks JB, Visser GH: Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. Br J Obstet Gynaecol 1997;104:1239-1247.
122. Mulder EJ, Derks JB, Visser GH: Effects of antenatal betamethasone administration on fetal heart rate and behavior in twin pregnancy. Pediatr Res 2004;56:35-39.
123. Mulder EJ, Koenen SV, Blom I, Visser GH: The effects of antenatal betamethasone administration on fetal heart rate and behaviour depend on gestational age. Early Hum Dev 2004;76:65-77.
124. Multon O, Senat MV, Minoui S, Hue MV, Frydman R, Ville Y: Effect of antenatal betamethasone and dexamethasone administration on fetal heart rate variability in growth-retarded fetuses. Fetal Diagn Ther 1997;12:170-177.
125. Rotmensch S, Liberati M, Celentano C, Efrat Z, Bar-Hava I, Kovo M, Golan A, Moravski G, Ben Rafael Z: The effect of betamethasone on fetal biophysical activities and Doppler velocimetry of umbilical and middle cerebral arteries. Acta Obstet Gynecol Scand 1999;78:768-773.
126. Senat MV, Minoui S, Multon O, Fernandez H, Frydman R, Ville Y: Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labour: a randomised study. Br J Obstet Gynaecol 1998;105:749-755.
127. Subtil D, Tiberghien P, Devos P, Therby D, Leclerc G, Vaast P, Puech F: Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomized trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. Am J Obstet Gynecol 2003;188:524-531.
128. Ville Y, Vincent Y, Tordjman N, Hue MV, Fernandez H, Frydman R: Effect of betamethasone on the fetal heart rate pattern assessed by computerized cardiotocography in normal twin pregnancies. Fetal Diagn Ther 1995;10:301-306.
129. Antonow-Schlorke I, Kühn B, Müller T, Schubert H, Sliwka U, Nathanielsz PW, Schwab M: Antenatal betamethasone treatment reduces synaptophysin in presynaptic terminals in the fetal sheep brain. Neurosci Lett 2001;297:147-150.
130. Antonow-Schlorke I, Müller T, Brodhun M, Wicher C, Schubert H, Nathanielsz PW, Witte OW, Schwab M: Betamethasone related acute alterations of microtubule associated proteins in the fetal sheep brain are reversible and independent of age during the last third of gestation. Am J Obstet Gynecol 2007;196:553.e1-6.
131. Antonow-Schlorke I, Schwab M, Li C, Nathanielsz PW: Glucocorticoid exposure at the dose used clinically alters cytoskeletal proteins and presynaptic terminals in the fetal baboon brain. J Physiol (Lond) 2003;547:117-123.
132. Colberg C, Antonow-Schlorke I, Müller T, Schubert H, Nathanielsz PW, Witte OW, Schwab M: Recovery of glucocorticoid-related loss of synaptic density in the fetal sheep brain at 0.75 of gestation. Neurosci Lett 2004;364:130-134.
133. Schwab M, Antonow-Schlorke I, Kühn B, Müller T, Schubert H, Walter B, Sliwka U, Nathanielsz PW: Effect of antenatal betamethasone treatment on microtubule associated proteins MAP1B and MAP2 in fetal sheep. J Physiol (Lond) 2001;530:497-506.
134. Schwab M, Wichmann G, Maurer I, Loehle M, Nathanielsz PW, Witte OW: Antenatal glucocorticoids suppress mitochondrial activity but do not decrease ATP content in the fetal ovine brain. J Soc Gynecol Invest 2006;13(suppl):732.
135. MacArthur BA, Howie RN, Dezoete JA, Elkins J: School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics 1982;70:99-105.
136. Collaborative Group on Antenatal Steroid Therapy: Effects of antenatal dexamethasone administration in the infant: long-term follow-up. J Pediatr 1984;104:259-267.
137. Dalziel SR, Lim VK, Lambert A, McCarthy D, Parag V, Rodgers A, Harding JE: Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ 2005;331:665-668.
138. Dessens AB, Haas HS, Koppe JG: Twenty-year follow-up of antenatal corticosteroid treatment. Pediatrics 2000;105:E77.
139. Schmand B, Neuvel J, Smolders-de Haas H, Hoeks J, Treffers PE, Koppe JG: Psychological development of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome. Pediatrics 1990;86:58-64.
140. Meyer-Bahlburg HF, Dolezal C, Baker SW, Carlson AD, Obeid JS, New MI: Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone. J Clin Endocrinol Metab 2004;89:610-614.
141. French NP, Hagan R, Evans SF, Mullan A, Newnham JP: Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. Am J Obstet Gynecol 2004;190:588-595.
142. Halliday HL: The effect of postnatal steroids on growth and development. J Perinat Med 2001;29:281-285.
143. Karemaker R, Heijnen CJ, Veen S, Baerts W, Samsom J, Visser GH, Kavelaars A, van Doornen LJ, van Bel F: Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone. Pediatr Res 2006;60:745-750.
144. Karemaker R, Kavelaars A, ter Wolbeek M, Tersteeg-Kamperman M, Baerts W, Veen S, Samsom JF, Visser GH, van Bel F, Heijnen CJ: Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age. Pediatrics 2008;121:e870-e878.
145. Needelman H, Evans M, Roberts H, Sweney M, Bodensteiner JB: Effects of postnatal dexamethasone exposure on the developmental outcome of premature infants. J Child Neurol 2008;23:421-424.
146. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, Tsai CH: Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004;350:1304-1313.
147. Brodhun M, Coksaygan T, Müller T, Antonow-Schlorke I, Schubert H, Patt S, Nathanielsz PW, Schwab M: Time and dose dependent effects of antenatal glucocorticoids on cell birth and death in the fetal sheep brain. J Soc Gynecol Invest 2004;11(suppl):533.
148. Antonow-Schlorke I, Helgert A, Gey C, Coksaygen T, Schubert H, Nathanielsz PW, Witte OW, Schwab M: Adverse effects of antenatal glucocorticoids on cerebral myelination in sheep. Obstet Gynecol, in press.
149. Bolt RJ, van Weissenbruch MM, Lafeber HN, Delemarre-van de Waal HA: Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol 2001;32:76-91.
150. Gould E, Tanapat P: Stress and hippocampal neurogenesis. Biol Psychiatry 1999;46:1472-1479.
151. Gould E, Cameron HA: Regulation of neuronal birth, migration and death in the rat dentate gyrus. Dev Neurosci 1996;18:22-35.
152. Guijarro C, Rutz S, Rothmaier K, Turiault M, Zhi Q, Naumann T, Frotscher M, Tronche F, Jackisch R, Kretz O: Maturation and maintenance of cholinergic medial septum neurons require glucocorticoid receptor signaling. J Neurochem 2006;97:747-758.
153. Nakai A, Shibazaki Y, Taniuchi Y, Oya A, Asakura H, Koshino T, Araki T: Effect of dexamethasone on mitochondrial maturation in the fetal rat brain. Am J Obstet Gynecol 2002;186:574-578.
154. Sapolsky RM, Meaney MJ: Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res 1986;396:64-76.
155. Sloviter RS, Sollas AL, Dean E, Neubort S: Adrenalectomy-induced granule cell degeneration in the rat hippocampal dentate gyrus: characterization of an in vivo model of controlled neuronal death. J Comp Neurol 1993;330:324-336.
156. Matthews SG: Antenatal glucocorticoids and programming of the developing CNS. Pediatr Res 2000;47:291-300.
157. Matthews SG: Antenatal glucocorticoids and the developing brain: mechanisms of action. Semin Neonatol 2001;6:309-317.
158. Amiel-Tison C, Cabrol D, Denver R, Jarreau PH, Papiernik E, Piazza PV: Fetal adaptation to stress. 1. Acceleration of fetal maturation and earlier birth triggered by placental insufficiency in humans. Early Hum Dev 2004;78:15-27.
159. Schwab M, Schwab K, Groh T, Kott M, Nathanielsz PW, Witte OW: Antenatal betamethasone treatment enhances development of ovine fetal brain function at the expense of a persistently altered sleep architecture. Pediatr Res 2005;58:1084.
160. Schwab K, Groh T, Coksaygen T, Müller T, Schubert H, Nathanielsz PW, Schwab M: Betamethasone treatment induces programming of glucocorticoid resistance and depression-like functional disturbances in the fetal sheep brain. Early Hum Dev 2007;83:S129.
161. Brodhun M, Coksaygan T, Müller T, Antonow-Schlorke I, Schubert H, Patt S, Nathanielsz PW, Schwab M: Time and dose dependent effects of antenatal glucocorticoids on cell birth and death in the fetal sheep brain. J Soc Gynecol Invest 2004;11(suppl):533.
162. Liu H, Kaur J, Dashtipour K, Kinyamu R, Ribak CE, Friedman LK: Suppression of hippocampal neurogenesis is associated with developmental stage, number of perinatal seizure episodes, and glucocorticosteroid level. Exp Neurol 2003;184:196-213.
163. Fujioka A, Fujioka T, Ishida Y, Maekawa T, Nakamura S: Differential effects of prenatal stress on the morphological maturation of hippocampal neurons. Neuroscience 2006;141:907-915.
164. McCormick JA, Lyons V, Jacobson MD, Noble J, Diorio J, Nyirenda M, Weaver S, Ester W, Yau JL, Meaney MJ, Seckl JR, Chapman KE:5′-Heterogeneity of glucocorticoid receptor messenger RNA is tissue specific: differential regulation of variant transcripts by early-life events. Mol Endocrinol 2000;14:506-517.
165. McArthur S, McHale E, Gillies GE: The size and distribution of midbrain dopaminergic populations are permanently altered by perinatal glucocorticoid exposure in a sex-, region- and time-specific manner. Neuropsychopharmacology 2007;32:1462-1476.
166. Shi B, Rabin SJ, Brandoli C, Mocchetti I: Dexamethasone induces hypertrophy of developing medial septum cholinergic neurons: potential role of nerve growth factor. J Neurosci 1998;18:9326-9334.
167. Bruschettini M, van den Hove DL, Gazzolo D, Bruschettini P, Blanco CE, Steinbusch HW: A single course of antenatal betamethasone reduces neurotrophic factor S100B concentration in the hippocampus and serum in the neonatal rat. Brain Res Dev Brain Res 2005;159:113-118.
168. Coe CL, Lubach GR: Developmental consequences of antenatal dexamethasone treatment in nonhuman primates. Neurosci Biobehav Rev 2005;29:227-235.
169. Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O, Holden J: Neurotoxicity of glucocorticoids in the primate brain. Horm Behav 1994;28:336-348.
170. Chao HM, Sakai RR, Ma LY, McEwen BS: Adrenal steroid regulation of neurotrophic factor expression in the rat hippocampus. Endocrinology 1998;139:3112-3118.
171. Zhang LX, Xing GO, Levine S, Post RM, Smith MA: Maternal deprivation induces neuronal death. Soc Neurosci Abstr 1997;23:1113.
172. Hassan AH, von Rosenstiel P, Patchev VK, Holsboer F, Almeida OF: Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone. Exp Neurol 1996;140:43-52.
173. Packan DR, Sapolsky RM: Glucocorticoid endangerment of the hippocampus: tissue, steroid and receptor specificity. Neuroendocrinology 1990;51:613-618.
174. Dunlop SA, Archer MA, Quinlivan JA, Beazley LD, Newnham JP: Repeated prenatal corticosteroids delay myelination in the ovine central nervous system. J Mat Fet Med 1997;6:309-313.
175. Huang WL, Harper CG, Evans SF, Newnham JP, Dunlop SA: Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep. Int J Dev Neurosci 2001;19:415-425.
176. Herlenius E, Lagercrantz H: Neurotransmitters and neuromodulators during early human development. Early Hum Dev 2001;65:21-37.
177. Hayashi A, Nagaoka M, Yamada K, Ichitani Y, Miake Y, Okado N: Maternal stress induces synaptic loss and developmental disabilities of offspring. Int J Dev Neurosci 1998;16:2092-2116.
178. Field T, Diego M, Hernandez-Reif M, Schanberg S, Kuhn C, Yando R, Bendell D: Pregnancy anxiety and comorbid depression and anger: effects on the fetus and neonate. Depress Anxiety 2003;17:140-151.
179. Dugovic C, Maccari S, Weibel L, Turek FW, Van Reeth O: High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. J Neurosci 1999;19:8656-8664.
180. Aghajafari F, Murphy K, Matthews S, Ohlsson A, Amankwah K, Hannah M: Repeated doses of antenatal corticosteroids in animals: a systematic review. Am J Obstet Gynecol 2002;186:843-849.
181. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP: Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 1999;180:114-121.
182. Moss TJ, Doherty DA, Nitsos I, Sloboda DM, Harding R, Newnham JP: Effects into adulthood of single or repeated antenatal corticosteroids in sheep. Am J Obstet Gynecol 2005;192:146-152.
183. Huang WL, Beazley LD, Quinlivan JA, Evans SF, Newnham JP, Dunlop SA: Effect of corticosteroids on brain growth in fetal sheep. Obstet Gynecol 1999;94:213-218.
184. Modi N, Lewis H, Al-Naqeeb N, Ajayi-Obe M, DoréCJ, Rutherford M: The effects of repeated antenatal glucocorticoid therapy on the developing brain. Pediatr Res 2001;50:581-585.
185. Murphy BP, Inder TE, Huppi PS, Warfield S, Zientara GP, Kikinis R, Jolesz FA, Volpe JJ: Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics 2001;107:217-221.
186. Gatford KL, Owens JA, Li S, Moss TJ, Newnham JP, Challis JR, Sloboda DM: Repeated betamethasone treatment of pregnant sheep programs persistent reductions in circulating IGF-I and IGF-binding proteins in progeny. Am J Physiol Endocrinol Metab 2008;295:E170-E178.
187. Thakur A, Sase M, Lee JJ, Thakur V, Buchmiller TL: Effect of dexamethasone on insulin-like growth factor-1 expression in a rabbit model of growth retardation. J Pediatr Surg 2000;35:898-904.
188. Fumagalli F, Molteni R, Racagni G, Riva MA: Stress during development: Impact on neuroplasticity and relevance to psychopathology. Prog Neurobiol 2007;81:197-217.
189. Lemaire V, Koehl M, Le Moal M, Abrous DN: Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc Natl Acad Sci USA 2000;97:11032-11037.
190. Son GH, Geum D, Chung S, Kim EJ, Jo JH, Kim CM, Lee KH, Kim H, Choi S, Kim HT, Lee CJ, Kim K: Maternal stress produces learning deficits associated with impairment of NMDA receptor-mediated synaptic plasticity. J Neurosci 2006;26:3309-3318.
191. Ulupinar E, Yucel F: Prenatal stress reduces interneuronal connectivity in the rat cerebellar granular layer. Neurotoxicol Teratol 2005;27:475-484.
192. Burlet G, Fernette B, Blanchard S, Angel E, Tankosic P, Maccari S, Burlet A: Antenatal glucocorticoids blunt the functioning of the hypothalamic- pituitary-adrenal axis of neonates and disturb some behaviors in juveniles. Neuroscience 2005;133:221-230.
193. Coe CL, Kramer M, Czéh B, Gould E, Reeves AJ, Kirschbaum C, Fuchs E: Prenatal stress diminishes neurogenesis in the dentate gyrus of juvenile rhesus monkeys. Biol Psychiatry 2003;54:1025-1034.
194. Ulupinar E, Yucel F, Ortug G: The effects of prenatal stress on the Purkinje cell neurogenesis. Neurotoxicol Teratol 2006;28:86-94.
195. Bremner JD, Elzinga B, Schmahl C, Vermetten E: Structural and functional plasticity of the human brain in posttraumatic stress disorder. Prog Brain Res 2008;167:171-186.
196. Sheline YI, Mittler BL, Mintun MA: The hippocampus and depression. Eur Psychiatry 2002;17(suppl 3):300-305.
197. Vythilingam M, Vermetten E, Anderson GM, Luckenbaugh D, Anderson ER, Snow J, Staib LH, Charney DS, Bremner JD: Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry 2004;56:101-112.
198. Belanoff JK, Gross K, Yager A, Schatzberg AF: Corticosteroids and cognition. J Psychiatr Res 2001;35:127-145.
199. Heffelfinger AK, Newcomer JW: Glucocorticoid effects on memory function over the human life span. Dev Psychopathol 2001;13:491-513.
200. Kim JJ, Haller J: Glucocorticoid hyper- and hypofunction: stress effects on cognition and aggression. Ann NY Acad Sci 2007;1113:291-303.
201. Lupien SJ, Fiocco A, Wan N, Maheu F, Lord C, Schramek T, Tu MT: Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology 2005;30:225-242.
202. Sapolsky RM: Stress and plasticity in the limbic system. Neurochem Res 2003;28:1735-1742.
203. Hanley NR, Van de Kar LD: Serotonin and the neuroendocrine regulation of the hypothalamic-pituitary-adrenal axis in health and disease. Vitam Horm 2003;66:189-255.
204. Slotkin TA, Barnes GA, McCook EC, Seidler FJ: Programming of brainstem serotonin transporter development by prenatal glucocorticoids. Brain Res Dev Brain Res 1996;93:155-161.
205. Slotkin TA, Lappi SE, McCook EC, Tayyeb MI, Eylers JP, Seidler FJ: Glucocorticoids and the development of neuronal function: effects of prenatal dexamethasone exposure on central noradrenergic activity. Biol Neonate 1992;61:326-336.
206. Muneoka K, Mikuni M, Ogawa T, Kitera K, Kamei K, Takigawa M, Takahashi K: Prenatal dexamethasone exposure alters brain monoamine metabolism and adrenocortical response in rat offspring. Am J Physiol 1997;273:R1669-R1675.
207. Bian X, Seidler FJ, Slotkin TA: Fetal dexamethasone exposure interferes with establishment of cardiac noradrenergic innervation and sympathetic activity. Teratology 1993;47:109-117.
208. Katz LM, Nathan L, Kuhn CM, Schanberg SM: Inhibition of GH in maternal separation may be mediated through altered serotonergic activity at 5-HT2A and 5-HT2C receptors. Psychoneuroendocrinology 1996;21:219-235.
209. Leão P, Sousa JC, Oliveira M, Silva R, Almeida OF, Sousa N: Programming effects of antenatal dexamethasone in the developing mesolimbic pathways. Synapse 2007;61:40-49.
210. McArthur S, McHale E, Dalley JW, Buckingham JC, Gillies GE: Altered mesencephalic dopaminergic populations in adulthood as a consequence of brief perinatal glucocorticoid exposure. J Neuroendocrinol 2005;17:475-482.
211. Roberts AD, Moore CF, DeJesus OT, Barnhart TE, Larson JA, Mukherjee J, Nickles RJ, Schueller MJ, Shelton SE, Schneider ML: Prenatal stress, moderate fetal alcohol, and dopamine system function in rhesus monkeys. Neurotoxicol Teratol 2004;26:169-178.
212. Day JC, Koehl M, Deroche V, Le Moal M, Maccari S: Prenatal stress enhances stress- and corticotropin-releasing factor-induced stimulation of hippocampal acetylcholine release in adult rats. J Neurosci 1998;18:1886-1892.
213. Stone DJ, Walsh JP, Sebro R, Stevens R, Pantazopolous H, Benes FM: Effects of pre- and postnatal corticosterone exposure on the rat hippocampal GABA system. Hippocampus 2001;11:492-507.
214. Schwab M, Antonow-Schlorke I, Schlabritz-Loutsevitch N, Stuchlik K, Levitz M, Cox L, McDonald TJ, Witte OW, Nathanielsz PW: Development of the cortical neuronal network in fetal baboons at 0.5 of gestation is altered by 30% maternal nutrient restriction. Pediatr Res 2005;58:1115.
215. King RS, DeBassio WA, Kemper TL, Rosene DL, Tonkiss J, Galler JR, Blatt GJ: Effects of prenatal protein malnutrition and acute postnatal stress on granule cell genesis in the fascia dentata of neonatal and juvenile rats. Brain Res Dev Brain Res 2004;150:9-15.
216. Silveira AC, Gardino PF, Bevilaqua MC, HokoçJN: Neurogenesis of GABAergic cells in the retina of malnourished rats. Int J Dev Neurosci 2007;25:325-333.
217. Morgane PJ, Mokler DJ, Galler JR: Effects of prenatal protein malnutrition on the hippocampal formation. Neurosci Biobehav Rev 2002;26:471-483.
218. Chang YM, Galler JR, Luebke JI: Prenatal protein malnutrition results in increased frequency of miniature inhibitory postsynaptic currents in rat CA3 interneurons. Nutr Neurosci 2003;6:263-267.
219. Kehoe P, Mallinson K, Bronzino J, McCormick CM: Effects of prenatal protein malnutrition and neonatal stress on CNS responsiveness. Brain Res Dev Brain Res 2001;132:23-31.
220. Mokler DJ, Galler JR, Morgane PJ: Modulation of 5-HT release in the hippocampus of 30-day-old rats exposed in utero to protein malnutrition. Brain Res Dev Brain Res 2003;142:203-208.
221. Alfaro-Rodríguez A, González-Piña R, González-Maciel A, Arch-Tirado E: Serotonin and 5-hydroxy-indole-acetic acid contents in dorsal raphe and suprachiasmatic nuclei in normal, malnourished and rehabilitated rats under 24 h of sleep deprivation. Brain Res 2006;1110:95-101.
222. Mokler DJ, Torres OI, Galler JR, Morgane PJ: Stress-induced changes in extracellular dopamine and serotonin in the medial prefrontal cortex and dorsal hippocampus of prenatally malnourished rats. Brain Res 2007;1148:226-233.
223. Bezchlibnyk YB, Xu L, Wang JF, Young LT: Decreased expression of insulin-like growth factor binding protein 2 in the prefrontal cortex of subjects with bipolar disorder and its regulation by lithium treatment. Brain Res 2007;1147:213-217.
224. Corcoran C, Walker E, Huot R, Mittal V, Tessner K, Kestler L, Malaspina D: The stress cascade and schizophrenia: etiology and onset. Schizophr Bull 2003;29:671-692.
225. Ferrari E, Cravello L, Muzzoni B, Casarotti D, Paltro M, Solerte SB, Fioravanti M, Cuzzoni G, Pontiggia B, Magri F: Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Eur J Endocrinol 2001;144:319-329.
226. Lupien SJ, Nair NP, Brière S, Maheu F, Tu MT, Lemay M, McEwen BS, Meaney MJ: Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci 1999;10:117-139.
227. Marx CE, Lieberman JA: Psychoneuroendocrinology of schizophrenia. Psychiatr Clin North Am 1998;21:413-444.
228. O'Connor JC, McCusker RH, Strle K, Johnson RW, Dantzer R, Kelley KW: Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell Immunol 2008;252:91-110.
229. Swaab DF, Bao AM, Lucassen PJ: The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 2005;4:141-194.
230. Porter NM, Landfield PW: Stress hormones and brain aging: adding injury to insult? Nat Neurosci 1998;1:3-4.
231. Cameron NM, Champagne FA, Parent C, Fish EW, Ozaki-Kuroda K, Meaney MJ: The programming of individual differences in defensive responses and reproductive strategies in the rat through variations in maternal care. Neurosci Biobehav Rev 2005;29:843-865.
232. Meaney MJ, Diorio J, Francis D, Weaver S, Yau J, Chapman K, Seckl JR: Postnatal handling increases the expression of cAMP-inducible transcription factors in the rat hippocampus: the effects of thyroid hormones and serotonin. J Neurosci 2000;20:3926-3935.
233. Manuck SB, Bleil ME, Petersen KL, Flory JD, Mann JJ, Ferrell RE, Muldoon MF: The socio-economic status of communities predicts variation in brain serotonergic responsivity. Psychol Med 2005;35:519-528.
234. Fisher MO, Nager RG, Monaghan P: Compensatory growth impairs adult cognitive performance. PLoS Biol 2006;4:e251.
235. Cianfarani S, Germani D, Branca F: Low birthweight and adult insulin resistance: the 'catch-up growth' hypothesis. Arch Dis Child 1999;81:F71-F73.
236. Ekelund U, Ong KK, Linne Y, Neovius M, Brage S, Dunger DB, Wareham NJ, Rossner S: Association of weight gain in infancy and early childhood with metabolic risk in young adults. J Clin Endocrinol Metab 2007;92:98-103.
237. Ezzahir N, Alberti C, Deghmoun S, Zaccaria I, Czernichow P, Levy-Marchal C, Jaquet D: Time course of catch-up in adiposity influences adult anthropometry in individuals who were born small for gestational age. Pediatr Res 2005;58:243-247.
238. Ibanez L, Ong K, Dunger DB, de Zegher F: Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children. J Clin Endocrinol Metab 2006;91:2153-2158.
239. Sapolsky RM, Pulsinelli WA: Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 1985;229:1397-1400.
240. Sugo N, Hurn PD, Morahan MB, Hattori K, Traystman RJ, DeVries AC: Social stress exacerbates focal cerebral ischemia in mice. Stroke 2002;33:1660-1664.
241. Leonard BE: The HPA and immune axes in stress: the involvement of the serotonergic system. Eur Psychiatry 2005;20:S302-S306.
242. Paul SL, Srikanth VK, Thrift AG: The large and growing burden of stroke. Curr Drug Targets. 2007;8:786-793.
243. Bonnet F, Irving K, Terra JL, Nony P, Berthezène F, Moulin P: Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome. J Hypertens 2005;23:611-617.
244. Heiskanen TH, Niskanen LK, Hintikka JJ, Koivumaa-Honkanen HT, Honkalampi KM, Haatainen KM, Viinamäki HT: Metabolic syndrome and depression: a cross-sectional analysis. J Clin Psychiatry 2006;67:1422-1427.
245. Kopf D, Westphal S, Luley CW, Ritter S, Gilles M, Weber-Hamann B, Lederbogen F, Lehnert H, Henn FA, Heuser I, Deuschle M: Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment. J Clin Psychopharmacol 2004;24:527-531.
246. Kales HC, Maixner DF, Mellow AM: Cerebrovascular disease and late-life depression. Am J Geriatr Psychiatry 2005;13:88-98.
247. Mast BT: Cerebrovascular disease and late-life depression: a latent-variable analysis of depressive symptoms after stroke. Am J Geriatr Psychiatry 2004;12:315-322.
248. Kuyper AM, Honig A: Treatment of postmyocardial infarction depressive disorder. Expert Rev Neurother 2008;8:1115-1123.
249. Johnson AK, Grippo AJ: Sadness and broken hearts: neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression. J Physiol Pharmacol 2006;57(suppl 11):5-29.
250. Von Ruden AE, Adson DE, Kotlyar M: Effect of selective serotonin reuptake inhibitors on cardiovascular morbidity and mortality. J Cardiovasc Pharmacol Ther 2008;13:32-40.
251. Davidson KW: Emotional predictors and behavioral triggers of acute coronary syndrome. Cleve Clin J Med 2008;75(suppl 2):S15-S19.
252. Frasure-Smith N, Lespérance F: Reflections on depression as a cardiac risk factor. Psychosom Med 2005;67(suppl 1):S19-S25.
253. Glassman AH: Depression and cardiovascular comorbidity. Dialogues Clin Neurosci 2007;9:9-17.
254. Goodwin GM: Depression and associated physical diseases and symptoms. Dialogues Clin Neurosci 2006;8:259-265.
255. Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U, Fauerbach JA, Bush DE, Ziegelstein RC: Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006;21:30-38.
256. Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A: Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry 2007;22:613-626.
257. Nilsson FM, Kessing LV: Increased risk of developing stroke for patients with major affective disorder - a registry study. Eur Arch Psychiatry Clin Neurosci 2004;254:387-391.
258. Smith PJ, Blumenthal JA, Babyak MA, Hoffman BM, Doraiswamy PM, Waugh R, Hinderliter A, Sherwood A: Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression. Psychosom Med 2007;69:578-586.
259. Surtees PG, Wainwright NW, Luben RN, Wareham NJ, Bingham SA, Khaw KT: Psychological distress, major depressive disorder, and risk of stroke. Neurology 2008;70:788-794.
260. Hackett ML, Anderson CS, House AO: Management of depression after stroke: a systematic review of pharmacological therapies. Stroke 2005;36:1098-1103.
261. Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, Fonzetti P, Hegel M, Arndt S: Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008;299:2391-2400.
262. Starkstein SE, Mizrahi R, Power BD: Antidepressant therapy in post-stroke depression. Expert Opin Pharmacother 2008;9:1291-1298.
263. Brown ES, Varghese FP, McEwen BS: Association of depression with medical illness: does cortisol play a role? Biol Psychiatry 2004;55:1-9.
264. Bruce EC, Musselman DL: Depression, alterations in platelet function, and ischemic heart disease. Psychosom Med 2005;67 (suppl 1):S34-S36.
265. de Castro AG, Bajbouj M, Schlattmann P, Lemke H, Heuser I, Neu P: Cerebrovascular reactivity in depressed patients without vascular risk factors. J Psychiatr Res 2008;42:78-82.
266. Girod JP, Brotman DJ: Does altered glucocorticoid homeostasis increase cardiovascular risk? Cardiovasc Res 2004;64:217-226.
267. Hackett ML, Anderson CS: Predictors of depression after stroke: a systematic review of observational studies. Stroke 2005;36:2296-2301.
268. Lespérance F, Frasure-Smith N, Théroux P, Irwin M: The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 2004;161:271-277.
269. Skala JA, Freedland KE, Carney RM: Coronary heart disease and depression: a review of recent mechanistic research. Can J Psychiatry 2006;51:738-745.
270. Wagner JA, Tennen H, Mansoor GA, Abbott G: History of major depressive disorder and endothelial function in postmenopausal women. Psychosom Med 2006;68:80-86.